Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
Addressed, aloe, CG, Chesen, exceptionally, fourteen, franchise, gel, GlaxoSmithKline, guaranty, Haleon, Henry, hybrid, inconsequential, infuse, infused, IPO, joint, JV, Leonard, mask, modification, Neil, Nelson, outsourced, proven, reach, recalculated, reclassified, remeasured, rollstock, salable, Scientific, Scott, Tegaderm, unrealized, vendor, venture, whichever
Removed:
acceleration, affiliate, agent, Alliqua, allocation, amendment, American, assumed, authorize, BioMedical, commenced, consolidation, consummation, Cova, deficit, departure, dilutive, disposition, Emergency, ending, enterprise, exact, exemption, existed, hand, indemnification, lived, objectivity, Organization, outbreak, paragraph, parent, preceding, pro, proforma, promulgated, rata, receive, reclassification, registration, separation, standalone, taxpayer, technique, terminated, tissue, treated, twenty, world, Yardley, York
Filing tables
Filing exhibits
Related press release
Associated NXGL transcripts
NXGL similar filings
Filing view
External links